Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Admission and Consent Documentation Impacts Timely Initiation of Home Care Services

Administrative delays in paperwork can keep patients waiting for care they urgently need at home

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By What The Home Health 2 · Art NicholasHome Care ServicesInterlace HealthMatthew Mulski
Share

Key takeaways

01

Administrative delays in paperwork can keep patients waiting for care they urgently need at home

In today’s rapidly evolving healthcare landscape, the timely initiation of home care services is more crucial than ever. With a growing emphasis on patient-centered care and the shift towards home health, streamlining administrative processes like admission and consent documentation has become essential. Inefficiencies in these processes can lead to delays in care, affecting patient outcomes and increasing healthcare costs.

Inefficiencies in these processes can lead to delays in care, affecting patient outcomes and increasing healthcare costs.

How can home care agencies improve their admission and consent documentation processes to ensure the timely initiation of home care services?

Welcome to What the Home Health. In this episode, host Matthew Mulski sits down with Art Nicholas, the Chief Commercial Officer at Interlace Health, to discuss the pivotal role of admission and consent documentation in home care services. Interlace Health automates clinical and patient workflows to reduce administrative time and improve patient experience.

Key Points of Discussion:

– The conflict between compliance and workflow efficiency in healthcare.

– Real-world impacts of inefficient documentation processes on home care services.

– Strategies for automating documentation to improve patient care and reduce administrative costs.

Art Nicholas, the Chief Commercial Officer at Interlace Health, brings over 15 years of experience in building high-growth sales, marketing, and business development teams. At Interlace Health, he has transformed healthcare solutions through innovative technology and strategic leadership. Art’s expertise includes go-to-market strategies, cross-functional team alignment, and fostering a culture of success, with affiliations in CHIME, HIMSS, and MUSE driving advancements in healthcare SaaS solutions.

About the author

WT
What The Home Health 2

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

WT
What The Home Health 2

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512